Table 1 Summary of study characteristics
From: The global economic burden of health anxiety/hypochondriasis- a systematic review
Authors | Publication Year | Country | Study Setting | Sample Size (n) Subgroups | Sex Female, n (%) | Age (years) i.) Age limit for inclusion ii.) Study population | Time Frame a) Data Collection b) Follow-up | Tool and Quality of Reporting |
|---|---|---|---|---|---|---|---|---|
Non-interventional studies for health anxiety/hypochondriasis | Â | Â | Â | Â | Â | |||
Barsky A. et al. [18] | 2001 | USA | Primary care clinic of Brigham and Women’s Hospital, Boston | 876 \(\ge\)ST: 212 \(<\)ST: 664 | \(\ge\)ST: / (75) \(<\)ST: / (72) | i.)\(\ge\)18 ii.) / | a) 1997-1998 b) 12 months | STROBE 68% |
Fink P. et al. [19] | 2010 | Denmark | Primary care patient’s consulting their family Physicians | 1129 mild HA: 21 severe HA: 81 DSM-IV: 59 CC: 968 | mild HA: / (61.9) severe HA: / (71.6) DSM-IV: / (79.6) CC: / (58.9) | i.) 18-65 ii.) mean (SD) mild HA: 39.1 (13.1) severe HA: 39.7 (13.7) DSM-IV: 38.4 (11.3) CC: 37.8 (13.1) | a) 2004 b) 3, 12, and 24 months | STROBE 79% |
Control groups of cognitive behaviour therapy (CBT) studies for health anxiety/hypochondriasis | Â | Â | Â | |||||
Tyrer P. et al. [26] | 2014 | United Kingdom | Six general hospitals covering urban, suburban, and rural areas | 444 CBT: 219 CC: 225 | CBT: 113 (52) CC: 123 (55) | i.) 16-75 ii.) mean (SD) CBT: 50.3 (13.6) CC: 47.0 (13.4) | a) 2008-2010 b) 24 months | CONSORT 78% |
Morriss R. et al. [21] | 2019 | United Kingdom | Primary and secondary care centres across the East Midlands and at two other English sites | 156 RCBT: 78 CC: 78 | RCBT: 56 (72) CC: 52 (67) | i.)\(\ge\)18 ii.) median (range) RCBT: 31.12 (18.36-70.10) CC: 33.28 (18.69-82.71) | a) 2014-2016 b) 12 months | CONSORT 78% |
Seivewright H. et al. [25] | 2008 | United Kingdom | Genitourinary medicine clinic King’s Mill Hospital, Sutton-in-Ashfield | 49 CBT: 23 CC: 26 | 23 (/) of total sample size | i.) 16-65 ii.) / | a) 2002-2005 b) 12 months | CONSORT 74% |
Hedman E. et al. [20] | 2012 | Sweden | Karolinska University Hospital, Stockholm | 81 iCBT: 40 CC: 41 | iCBT: 28 (/) CC: 32 (/) | i.) / ii.) mean (SD) iCBT: 39.3 (9.8) CC: 38.8 (9.5) | a) / b) 12 months | CONSORT 66% |
Risør et al. [24] | 2022 | Denmark | Research Clinic for Functional Disorders and Psychosomatics at Aarhus University Hospital | 101 iACT: 53 iFORUM: 48 | iACT: 34 (64) iFORUM: 32 (67) | i)\(\ge\)18 ii) mean (SD) iACT: 37.2 (9.7) iFORUM: 42.3 (9.6) | a) 2016-2017 b) 6 months | CONSORT 68% |
Axelsson et al. [17] | 2018 | Sweden | Karolinska University Hospital, Stockholm | 132 G-ICBT: 32 U-ICBT: 33 BIB-CBT: 34 WLC: 33 | G-ICBT: 24 (75) U-ICBT: 24 (73) BIB-CBT: 24 (71) WLC: 36 (79) | i)\(\ge\)18 ii) mean (SD) G-ICBT: 38.6 (12.6) U-ICBT: 37.4 (11.6) BIB-CBT: 35.4 (12.4) WLC: 41.5 (13.5) | a) 2013-2016 b) 12 months | CONSORT 73% |
Health anxiety in children | Â | Â | Â | Â | ||||
Rask C. U. et al. [22] | 2015 | Denmark | Copenhagen Child Cohort 2000 | 1884 low HA: 184 intermediate HA: 1539 high HA: 161 | low HA: 76 (41.3) intermediate HA: 812 (52.8) high HA: 99 (61.5) | i.) 11-12 ii.) / | a) 2011-2012 b) / | STROBE 81% |
Rimvall M. K. et al. [23] | 2020 | Denmark | Copenhagen Child Cohort 2000 | 1884 (2011) 1278 (2016) | 707 (55.3) of total sample size 2016 | i.) 11 and 16 ii.) / | a) 2011-2012; 2016-2017 b) / | STROBE 78% |